The use of glucagon-like peptide-1 receptor agonists is likely to increase the risks of inadequate bowel preparation for colonoscopy, according to a study published Feb. 12 in The American Journal of ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
The SYNGAP1 gene, which supports the production of a protein called SynGAP (Synaptic Ras GTPase-Activating Protein), is known ...
7h
The Brighterside of News on MSNOzempic found to reduce cravings for alcohol, heavy drinkingAlcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It ...
Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results